Relevant bibliographies by topics / Nemalobuněčný plicní karcinom

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Nemalobuněčný plicní karcinom'

Author: Grafiati
Published: 4 June 2021
Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Nemalobuněčný plicní karcinom.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Nemalobuněčný plicní karcinom"

1

Skřičková, Jana, Bohdan Kadlec, and Ondřej Venclíček. "Non-small cell lung cancer." Vnitřní lékařství 63, no. 11 (2017): 861–74. http://dx.doi.org/10.36290/vnl.2017.159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Venclíček, Ondřej. "Treatment of patients with non-small cell lung cancer with ALK rearrangement." Onkologie 12, no. 4 (2018): 182–84. http://dx.doi.org/10.36290/xon.2018.033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stejskal, Jan. "Serious complications in a patient with generalized non-small cell lung cancer treated with pembrolizumab." Onkologie 14, Suppl.A (2020): 17–20. http://dx.doi.org/10.36290/xon.2020.030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Skřičková, Jana, Kateřina Fröhlich, Matyáš Kuhn, et al. "Continuation maintenance therapy with pemetrexed in patients with non-small-cell lung cancer in the Czech Republic." Onkologie 10, no. 1 (2016): 31–36. http://dx.doi.org/10.36290/xon.2016.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Koubková, Leona. "Case report of a patient with metastatic non-small cell lung cancer with positive ALK gene rearrangement treated in the first line with alectinib." Onkologie 14, Suppl.D (2020): 71–74. http://dx.doi.org/10.36290/xon.2020.042.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Nemalobuněčný plicní karcinom"

1

Kulda, Vlastimil. "Regulace genové exprese v nádorové tkáni." Doctoral thesis, 2018. http://www.nusl.cz/ntk/nusl-388199.

Full text
Abstract:
Deregulation of gene expression caused by genetic or epigenetic changes plays an important role in pathogenesis of cancer. The thesis is a commented collection of ten publications dealing with the molecular biology of tumours. The author has significantly contributed to all of them. All the articles contained in the thesis are linked to the topic of assessment of molecules involved in gene expression regulation (microRNAs) or DNA alterations that affect gene expression (promoter methylation, presence of a fusion gene). MicroRNAs are short single-stranded RNA molecules involved in posttranscrip
APA, Harvard, Vancouver, ISO, and other styles
2

Vojtíšek, Radovan. "Vliv PET/CT vyšetření při plánování radioterapie nemalobuněčných plicních karcinomů." Doctoral thesis, 2015. http://www.nusl.cz/ntk/nusl-350104.

Full text
Abstract:
The impact of PET/CT scanning in the radiotherapy planning of non-small cell lung cancer Background: In the current practice of radiotherapy planning and target volume determination in patients suffering from the non-small cell lung cancer (NSCLC), a contrast-enhanced CT is standard procedure. Contemporary studies have proven that PET/CT examination attains higher sensitivity and specificity in the diagnosis of lung cancer and also leads to higher accuracy in the process of target-volume delineation in NSCLC. Aim: To compare radiotherapy plans made according to CT and PET/CT examinations in th
APA, Harvard, Vancouver, ISO, and other styles
3

Fikrová, Petra. "Hodnocení poškození a reparace DNA u pacientů s nemalobuněčným plicním karcinomem vzhledem k farmakoterapii deriváty platiny." Doctoral thesis, 2013. http://www.nusl.cz/ntk/nusl-328222.

Full text
Abstract:
Charles University in Prague Faculty of Pharmacy in Hradec Kralove Department of Biological and Medical Sciences Candidate: Mgr. Petra Fikrová Supervisor: Doc. PharmDr. Miloslav Hronek, Ph.D. Consultant: Prof. RNDr. Rudolf Štětina, CSc. Title of doctoral thesis: Evaluation of DNA damage and repair in patients with non-small cell lung cancer due to drug therapy with platinum derivatives Lung cancer is the most common worldwide cause of cancer-related death. This type of cancer is divided into two subtypes, the small cell and non-small cell lung cancer. Platinum- based chemotherapy is the mainst
APA, Harvard, Vancouver, ISO, and other styles
4

Pražáková, Markéta. "Klinický význam biomarkerů pro posouzení agresivity a prognozu nemalobuněčného karcinomu plic." Doctoral thesis, 2011. http://www.nusl.cz/ntk/nusl-358410.

Full text
Abstract:
Aim: The aim of this thesis was to measure a large spectrum of biomarkers in serum or plasma of patients with operable stage of NSCLC and to evaluate and compare the clinical utility of these biomarkers in the three most important clinical applications for NSCLC: diagnosis, prognosis and postsurgery follow up care. Patients and methods: Total of 22 biomarkers with the most promising profiles were monitored: 8 standard tumor markers (cytokeratines Cyfra 21-1, TPA, TPS, and MonoTotal, CEA, SCC, TK, Chromogranin A) and 14 potential useful biomarkers including pro-inflammatory cytokines IL-6, IL-8
APA, Harvard, Vancouver, ISO, and other styles
5

Rozkoš, Tomáš. "Stanovení optimálního vyšetřovacího algoritmu pro efektivní vyhledávání nemalobuněčných karcinomů plic s přestavbou genu ALK." Doctoral thesis, 2017. http://www.nusl.cz/ntk/nusl-308952.

Full text
Abstract:
(Identification of optimal algorithm for effective diagnostics of non-small cell lung carcinoma with ALK gene rearrangement - implementation of the method and practical experience with routine diagnostics) INTRODUCTION: Smaller subgroup of non-small cell lung carcinoma (NSCLC) is represented by tumours with carcinogenesis iniciated by fusion of ALK gene with another partner (usually EML4). Patients with ALK gene rearrangement treated with ALK inhibitors have significantly prolonged survival. Since ALK gene rearrangement is described according to the current WHO classification in 4-5% of NSCLC,
APA, Harvard, Vancouver, ISO, and other styles
6

Fiala, Ondřej. "Možnosti predikce efektu léčby EGFR tyrozinkinázovými inhibitory u pacientů s pokročilým nemalobuněčným karcinomem plic." Doctoral thesis, 2014. http://www.nusl.cz/ntk/nusl-342344.

Full text
Abstract:
Introduction: Targeted therapy with low molecular-weight tyrosine kinase inhibitors (TKI) directed at inhibition of epidermal growth factor receptor (EGFR) is a novel effective option for systemic treatment of locally-advanced or metastatic non-small cell lung cancer (NSCLC). Finding biomarkers that predict the efficacy of targeted treatment may increase the treatment efficacy and also prolong survival of patients. Aims: To assess the frequency of activating EGFR mutations and KRAS mutations in our patients and their role for prediction of EGFR-TKI treatment efficacy. To compare the efficacy a
APA, Harvard, Vancouver, ISO, and other styles
7

Kobosilová, Linda. "Exprese markerů imunogenní buněčné smrti na buňkách karcinomu plic." Master's thesis, 2014. http://www.nusl.cz/ntk/nusl-332417.

Full text
Abstract:
Immunogenic cell death (ICD) is characterized by presence of specific molecules including surface exposed calreticulin (CRT) and the heat shock proteins HSP70 and HSP90. Release of ATP and high- mobility group box protein 1 (HMGB1) belongs to other typical characteristics. For induction of ICD in lung cancer cells high-hydrostatic pressure (HHP) was used. Treatment by HHP induces expression of immunogenic markers CRT, HSP70 and HSP90 on the cell surface. HHP also induces secretion of ATP to the extracellular milieu. Dendritic cells (DC) pulsed with HHP-treated tumor cells showed fenotypic matu
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography